UPSHER-SMITH 200 mg (Qudexy XR 200 mg)
Generic Name: topiramate
Pill imprint UPSHER-SMITH 200 mg has been identified as Qudexy XR 200 mg.
Qudexy XR is used in the treatment of seizure prevention; lennox-gastaut syndrome; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Qudexy XR 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- UPSHER-SMITH 200 mg
- 200 mg
- Brown / Gray
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Upsher-Smith Laboratories, Inc.
More about Qudexy XR (topiramate)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: carbonic anhydrase inhibitor anticonvulsants
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.